Logo image
Innovative diagnostic tools for early detection of Alzheimer's disease
Journal article   Peer reviewed

Innovative diagnostic tools for early detection of Alzheimer's disease

C. Laske, H.R. Sohrabi, S.M. Frost, K. López-de-Ipiña, P. Garrard, M. Buscema, J. Dauwels, S.R. Soekadar, S. Mueller, C. Linnemann, …
Alzheimer's & Dementia, Vol.11(5), pp.561-578
2014
url
Link to Published Version *Subscription may be requiredView

Abstract

Current state‐of‐the‐art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time‐consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost‐effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.60 Dementia
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior
Logo image